Aller au contenu principal
Profil bibliographique

Friederike Münn

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
761Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesBone fractures and treatmentsVaccine Coverage and HesitancyAnimal Virus Infections Studies

Les publications récentes

Accès ouvert 2023 article OpenAlex

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19

Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica Di Cristanziano et autres

BACKGROUNDAfter its introduction as standard-of-care for severe COVID-19, dexamethasone has been administered to a large number of patients globally. Detailed knowledge of its impact on the cellular and humoral immune response to SARS-CoV-2 remains scarce.METHODSWe included immunocompetent individuals with (a) mild COVID-19, …

de (code pays fourni par la source)

6 citations JCI Insight
Accès ouvert 2022 article OpenAlex

Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis

Tilman Lingscheid, Martina Kinzig, Anne Krüger, Nils B. Müller et autres

Nirmatrelvir/ritonavir is an effective antiviral therapy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Use is not recommended in patients with end-stage renal disease (ESDR) due to a lack of data. We investigated the pharmacokinetics of nirmatrelvir/ritonavir (150 mg/100 mg twice a …

de (code pays fourni par la source)

33 citations Antimicrobial Agents and Chemotherapy
Accès ouvert 2022 preprint OpenAlex

Pharmacokinetics of nirmatrelvir and ritonavir in COVID-19 patients with end stage renal disease on intermittent haemodialysis

Tilman Lingscheid, Martina Kinzig, Anne Krüger, Nils B. Müller et autres

Abstract Background Nirmatrelvir/ritonavir is an effective therapy against SARS-CoV-2. Patients with end-stage renal disease (ESRD) are at high risk for severe COVID-19 and show impaired vaccine responses underlining the importance of antiviral therapy. However, use of nirmatrelvir/ritonavir is not recommended in these …

de (code pays fourni par la source)

0 citations medRxiv
Accès ouvert 2022 preprint OpenAlex

Delineating antibody escape from Omicron sublineages

Henning Gruell, Kanika Vanshylla, Michael Korenkov, Pinkus Tober‐Lau et autres

Abstract SARS-CoV-2 neutralizing antibodies play a critical role in prevention and treatment of COVID-19 but are challenged by viral evolution and antibody evasion, exemplified by the highly resistant Omicron BA.1 sublineage. 1–12 Importantly, the recently identified Omicron sublineages BA.2.12.1 and BA.4/5 with …

de (code pays fourni par la source)

17 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2022 preprint OpenAlex

Durability of Omicron-neutralizing serum activity following mRNA booster immunization in elderly individuals

Kanika Vanshylla, Pinkus Tober‐Lau, Henning Gruell, Friederike Münn et autres

Abstract Elderly individuals are at high risk for severe COVID-19. Due to modest vaccine responses compared to younger individuals and the time elapsed since prioritized vaccinations, the emerging immune-evasive Omicron variant of SARS-CoV-2 is a particular concern for the elderly. Here we …

de (code pays fourni par la source)

1 citation medRxiv
Accès ouvert 2022 article OpenAlex

A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany

A. V. Grishina, Fabian Link, Arne Arend, Florentine Kleemann et autres

BACKGROUND: The SARS-CoV‑2 pandemic has extensively challenged healthcare systems all over the world. Many elective operations were postponed or cancelled, changing priorities and workflows in surgery departments. AIMS: The primary aim of this cross-sectional study was to assess the workload and psychosocial …

de, gb (code pays fourni par la source)

1 citation Wiener klinische Wochenschrift
Accès ouvert 2021 article OpenAlex

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021

Pinkus Tober‐Lau, Tatjana Schwarz, David Hillus, Jana Spieckermann et autres

One week after second vaccinations were administered, an outbreak of B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility in Berlin, Germany, affecting 16/20 vaccinated and 4/4 unvaccinated residents. Despite considerable viral loads, vaccinated residents experienced …

de, gb (code pays fourni par la source)

20 citations Emerging infectious diseases
Accès ouvert 2021 article OpenAlex

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

Tatjana Schwarz, Pinkus Tober‐Lau, David Hillus, Elisa T. Helbig et autres

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (median age 34 years) in Germany. These data emphasize that nonpharmaceutical interventions for coronavirus disease remain crucial …

86 citations Emerging infectious diseases
Accès ouvert 2021 article OpenAlex

Detection of missed fractures of hand and forearm in whole-body CT in a blinded reassessment

Simon Kim, Leonie Goelz, Friederike Münn, D. Kim et autres

BACKGROUND: We examined the visibility of fractures of hand and forearm in whole-body CT and its influence on delayed diagnosis. This study is based on a prior study on delayed diagnosis of fractures of hand and forearm in patients with suspected polytrauma. …

de (code pays fourni par la source)

6 citations BMC Musculoskeletal Disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.